Health

BCMA CAR-T Yields 100% Response Rate in Small AL Amyloidosis Trial

TribeNews
By TribeNews Add a Comment
0 Min Read
BCMA CAR-T Yields 100% Response Rate in Small AL Amyloidosis Trial

MedPage Today) — As CAR T-cell therapy has become a transformative option in multiple myeloma, a first-of-its-kind trial now extends that potential to relapsed/refractory light chain (AL) amyloidosis. At the recent American Society of Clinical…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app